調査レポート | • レポートコード：GIR-2104Z03852 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、臍帯血幹細胞のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。臍帯血幹細胞の種類別市場規模（同種幹細胞、自家幹細胞）、用途別市場規模（自己免疫疾患、免疫不全、悪性腫瘍、がん、固形腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・臍帯血幹細胞の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Advanced Cell Technology、California Stem Cell、Cytori Therapeutics、Mesoblast Limited、Opexa Therapeutics Inc.、Athersys Inc.、Geron Corporation、Neostem Inc.、CBR Systems, Inc.、Cordlife、Cryo-Cell、Cryo-Save AG (A Group of Esperite)、Lifecell、Stemcyte、Viacord、Smart Cells International Ltd.、Cryoviva India、Cordvida、China Cord Blood Corporation ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：同種幹細胞、自家幹細胞 ・用途別分析2016年-2026年：自己免疫疾患、免疫不全、悪性腫瘍、がん、固形腫瘍、その他 ・臍帯血幹細胞の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・臍帯血幹細胞のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・臍帯血幹細胞のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・臍帯血幹細胞の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・臍帯血幹細胞の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cord Blood Stem Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cord Blood Stem Cells size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Cord Blood Stem Cells market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cord Blood Stem Cells market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Allogeneic Stem Cell
Autologous Stem Cell
Market segment by Application, can be divided into
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
Market segment by players, this report covers
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cord Blood Stem Cells
1.2 Classification of Cord Blood Stem Cells by Type
1.2.1 Overview: Global Cord Blood Stem Cells Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cord Blood Stem Cells Revenue Market Share by Type in 2020
1.2.3 Allogeneic Stem Cell
1.2.4 Autologous Stem Cell
1.3 Global Cord Blood Stem Cells Market by Application
1.3.1 Overview: Global Cord Blood Stem Cells Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Autoimmune Diseases
1.3.3 Immunodeficiencies
1.3.4 Malignancies,Caners
1.3.5 Solid Tumors
1.3.6 Others
1.4 Global Cord Blood Stem Cells Market Size & Forecast
1.5 Global Cord Blood Stem Cells Market Size and Forecast by Region
1.5.1 Global Cord Blood Stem Cells Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cord Blood Stem Cells Market Size by Region, (2016-2021)
1.5.3 North America Cord Blood Stem Cells Market Size and Prospect (2016-2026)
1.5.4 Europe Cord Blood Stem Cells Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cord Blood Stem Cells Market Size and Prospect (2016-2026)
1.5.6 South America Cord Blood Stem Cells Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cord Blood Stem Cells Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cord Blood Stem Cells Market Drivers
1.6.2 Cord Blood Stem Cells Market Restraints
1.6.3 Cord Blood Stem Cells Trends Analysis
2 Company Profiles
2.1 Advanced Cell Technology
2.1.1 Advanced Cell Technology Details
2.1.2 Advanced Cell Technology Major Business
2.1.3 Advanced Cell Technology Cord Blood Stem Cells Product and Solutions
2.1.4 Advanced Cell Technology Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Advanced Cell Technology Recent Developments and Future Plans
2.2 California Stem Cell
2.2.1 California Stem Cell Details
2.2.2 California Stem Cell Major Business
2.2.3 California Stem Cell Cord Blood Stem Cells Product and Solutions
2.2.4 California Stem Cell Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 California Stem Cell Recent Developments and Future Plans
2.3 Cytori Therapeutics
2.3.1 Cytori Therapeutics Details
2.3.2 Cytori Therapeutics Major Business
2.3.3 Cytori Therapeutics Cord Blood Stem Cells Product and Solutions
2.3.4 Cytori Therapeutics Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Cytori Therapeutics Recent Developments and Future Plans
2.4 Mesoblast Limited
2.4.1 Mesoblast Limited Details
2.4.2 Mesoblast Limited Major Business
2.4.3 Mesoblast Limited Cord Blood Stem Cells Product and Solutions
2.4.4 Mesoblast Limited Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Mesoblast Limited Recent Developments and Future Plans
2.5 Opexa Therapeutics Inc.
2.5.1 Opexa Therapeutics Inc. Details
2.5.2 Opexa Therapeutics Inc. Major Business
2.5.3 Opexa Therapeutics Inc. Cord Blood Stem Cells Product and Solutions
2.5.4 Opexa Therapeutics Inc. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Opexa Therapeutics Inc. Recent Developments and Future Plans
2.6 Athersys Inc.
2.6.1 Athersys Inc. Details
2.6.2 Athersys Inc. Major Business
2.6.3 Athersys Inc. Cord Blood Stem Cells Product and Solutions
2.6.4 Athersys Inc. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Athersys Inc. Recent Developments and Future Plans
2.7 Geron Corporation
2.7.1 Geron Corporation Details
2.7.2 Geron Corporation Major Business
2.7.3 Geron Corporation Cord Blood Stem Cells Product and Solutions
2.7.4 Geron Corporation Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Geron Corporation Recent Developments and Future Plans
2.8 Neostem Inc.
2.8.1 Neostem Inc. Details
2.8.2 Neostem Inc. Major Business
2.8.3 Neostem Inc. Cord Blood Stem Cells Product and Solutions
2.8.4 Neostem Inc. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Neostem Inc. Recent Developments and Future Plans
2.9 CBR Systems, Inc.
2.9.1 CBR Systems, Inc. Details
2.9.2 CBR Systems, Inc. Major Business
2.9.3 CBR Systems, Inc. Cord Blood Stem Cells Product and Solutions
2.9.4 CBR Systems, Inc. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 CBR Systems, Inc. Recent Developments and Future Plans
2.10 Cordlife
2.10.1 Cordlife Details
2.10.2 Cordlife Major Business
2.10.3 Cordlife Cord Blood Stem Cells Product and Solutions
2.10.4 Cordlife Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Cordlife Recent Developments and Future Plans
2.11 Cryo-Cell
2.11.1 Cryo-Cell Details
2.11.2 Cryo-Cell Major Business
2.11.3 Cryo-Cell Cord Blood Stem Cells Product and Solutions
2.11.4 Cryo-Cell Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Cryo-Cell Recent Developments and Future Plans
2.12 Cryo-Save AG (A Group of Esperite)
2.12.1 Cryo-Save AG (A Group of Esperite) Details
2.12.2 Cryo-Save AG (A Group of Esperite) Major Business
2.12.3 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Product and Solutions
2.12.4 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Cryo-Save AG (A Group of Esperite) Recent Developments and Future Plans
2.13 Lifecell
2.13.1 Lifecell Details
2.13.2 Lifecell Major Business
2.13.3 Lifecell Cord Blood Stem Cells Product and Solutions
2.13.4 Lifecell Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Lifecell Recent Developments and Future Plans
2.14 Stemcyte
2.14.1 Stemcyte Details
2.14.2 Stemcyte Major Business
2.14.3 Stemcyte Cord Blood Stem Cells Product and Solutions
2.14.4 Stemcyte Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Stemcyte Recent Developments and Future Plans
2.15 Viacord
2.15.1 Viacord Details
2.15.2 Viacord Major Business
2.15.3 Viacord Cord Blood Stem Cells Product and Solutions
2.15.4 Viacord Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Viacord Recent Developments and Future Plans
2.16 Smart Cells International Ltd.
2.16.1 Smart Cells International Ltd. Details
2.16.2 Smart Cells International Ltd. Major Business
2.16.3 Smart Cells International Ltd. Cord Blood Stem Cells Product and Solutions
2.16.4 Smart Cells International Ltd. Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Smart Cells International Ltd. Recent Developments and Future Plans
2.17 Cryoviva India
2.17.1 Cryoviva India Details
2.17.2 Cryoviva India Major Business
2.17.3 Cryoviva India Cord Blood Stem Cells Product and Solutions
2.17.4 Cryoviva India Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Cryoviva India Recent Developments and Future Plans
2.18 Cordvida
2.18.1 Cordvida Details
2.18.2 Cordvida Major Business
2.18.3 Cordvida Cord Blood Stem Cells Product and Solutions
2.18.4 Cordvida Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Cordvida Recent Developments and Future Plans
2.19 China Cord Blood Corporation
2.19.1 China Cord Blood Corporation Details
2.19.2 China Cord Blood Corporation Major Business
2.19.3 China Cord Blood Corporation Cord Blood Stem Cells Product and Solutions
2.19.4 China Cord Blood Corporation Cord Blood Stem Cells Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 China Cord Blood Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cord Blood Stem Cells Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Cord Blood Stem Cells Players Market Share
3.2.2 Top 10 Cord Blood Stem Cells Players Market Share
3.2.3 Market Competition Trend
3.3 Cord Blood Stem Cells Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cord Blood Stem Cells Revenue and Market Share by Type (2016-2021)
4.2 Global Cord Blood Stem Cells Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cord Blood Stem Cells Revenue Market Share by Application (2016-2021)
5.2 Cord Blood Stem Cells Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cord Blood Stem Cells Revenue by Type (2016-2026)
6.2 North America Cord Blood Stem Cells Revenue by Application (2016-2026)
6.3 North America Cord Blood Stem Cells Market Size by Country
6.3.1 North America Cord Blood Stem Cells Revenue by Country (2016-2026)
6.3.2 United States Cord Blood Stem Cells Market Size and Forecast (2016-2026)
6.3.3 Canada Cord Blood Stem Cells Market Size and Forecast (2016-2026)
6.3.4 Mexico Cord Blood Stem Cells Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cord Blood Stem Cells Revenue by Type (2016-2026)
7.2 Europe Cord Blood Stem Cells Revenue by Application (2016-2026)
7.3 Europe Cord Blood Stem Cells Market Size by Country
7.3.1 Europe Cord Blood Stem Cells Revenue by Country (2016-2026)
7.3.2 Germany Cord Blood Stem Cells Market Size and Forecast (2016-2026)
7.3.3 France Cord Blood Stem Cells Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cord Blood Stem Cells Market Size and Forecast (2016-2026)
7.3.5 Russia Cord Blood Stem Cells Market Size and Forecast (2016-2026)
7.3.6 Italy Cord Blood Stem Cells Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cord Blood Stem Cells Revenue by Type (2016-2026)
8.2 Asia-Pacific Cord Blood Stem Cells Revenue by Application (2016-2026)
8.3 Asia-Pacific Cord Blood Stem Cells Market Size by Region
8.3.1 Asia-Pacific Cord Blood Stem Cells Revenue by Region (2016-2026)
8.3.2 China Cord Blood Stem Cells Market Size and Forecast (2016-2026)
8.3.3 Japan Cord Blood Stem Cells Market Size and Forecast (2016-2026)
8.3.4 South Korea Cord Blood Stem Cells Market Size and Forecast (2016-2026)
8.3.5 India Cord Blood Stem Cells Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cord Blood Stem Cells Market Size and Forecast (2016-2026)
8.3.7 Australia Cord Blood Stem Cells Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cord Blood Stem Cells Revenue by Type (2016-2026)
9.2 South America Cord Blood Stem Cells Revenue by Application (2016-2026)
9.3 South America Cord Blood Stem Cells Market Size by Country
9.3.1 South America Cord Blood Stem Cells Revenue by Country (2016-2026)
9.3.2 Brazil Cord Blood Stem Cells Market Size and Forecast (2016-2026)
9.3.3 Argentina Cord Blood Stem Cells Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cord Blood Stem Cells Revenue by Type (2016-2026)
10.2 Middle East & Africa Cord Blood Stem Cells Revenue by Application (2016-2026)
10.3 Middle East & Africa Cord Blood Stem Cells Market Size by Country
10.3.1 Middle East & Africa Cord Blood Stem Cells Revenue by Country (2016-2026)
10.3.2 Turkey Cord Blood Stem Cells Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cord Blood Stem Cells Market Size and Forecast (2016-2026)
10.3.4 UAE Cord Blood Stem Cells Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cord Blood Stem Cells Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cord Blood Stem Cells Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cord Blood Stem Cells Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cord Blood Stem Cells Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cord Blood Stem Cells Revenue Market Share by Region (2021-2026)
Table 6. Advanced Cell Technology Corporate Information, Head Office, and Major Competitors
Table 7. Advanced Cell Technology Major Business
Table 8. Advanced Cell Technology Cord Blood Stem Cells Product and Solutions
Table 9. Advanced Cell Technology Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. California Stem Cell Corporate Information, Head Office, and Major Competitors
Table 11. California Stem Cell Major Business
Table 12. California Stem Cell Cord Blood Stem Cells Product and Solutions
Table 13. California Stem Cell Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Cytori Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. Cytori Therapeutics Major Business
Table 16. Cytori Therapeutics Cord Blood Stem Cells Product and Solutions
Table 17. Cytori Therapeutics Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Mesoblast Limited Corporate Information, Head Office, and Major Competitors
Table 19. Mesoblast Limited Major Business
Table 20. Mesoblast Limited Cord Blood Stem Cells Product and Solutions
Table 21. Mesoblast Limited Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Opexa Therapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Opexa Therapeutics Inc. Major Business
Table 24. Opexa Therapeutics Inc. Cord Blood Stem Cells Product and Solutions
Table 25. Opexa Therapeutics Inc. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Athersys Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Athersys Inc. Major Business
Table 28. Athersys Inc. Cord Blood Stem Cells Product and Solutions
Table 29. Athersys Inc. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Geron Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Geron Corporation Major Business
Table 32. Geron Corporation Cord Blood Stem Cells Product and Solutions
Table 33. Geron Corporation Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Neostem Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Neostem Inc. Major Business
Table 36. Neostem Inc. Cord Blood Stem Cells Product and Solutions
Table 37. Neostem Inc. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. CBR Systems, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. CBR Systems, Inc. Major Business
Table 40. CBR Systems, Inc. Cord Blood Stem Cells Product and Solutions
Table 41. CBR Systems, Inc. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Cordlife Corporate Information, Head Office, and Major Competitors
Table 43. Cordlife Major Business
Table 44. Cordlife Cord Blood Stem Cells Product and Solutions
Table 45. Cordlife Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Cryo-Cell Corporate Information, Head Office, and Major Competitors
Table 47. Cryo-Cell Major Business
Table 48. Cryo-Cell Cord Blood Stem Cells Product and Solutions
Table 49. Cryo-Cell Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Cryo-Save AG (A Group of Esperite) Corporate Information, Head Office, and Major Competitors
Table 51. Cryo-Save AG (A Group of Esperite) Major Business
Table 52. Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Product and Solutions
Table 53. Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Lifecell Corporate Information, Head Office, and Major Competitors
Table 55. Lifecell Major Business
Table 56. Lifecell Cord Blood Stem Cells Product and Solutions
Table 57. Lifecell Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Stemcyte Corporate Information, Head Office, and Major Competitors
Table 59. Stemcyte Major Business
Table 60. Stemcyte Cord Blood Stem Cells Product and Solutions
Table 61. Stemcyte Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Viacord Corporate Information, Head Office, and Major Competitors
Table 63. Viacord Major Business
Table 64. Viacord Cord Blood Stem Cells Product and Solutions
Table 65. Viacord Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Smart Cells International Ltd. Corporate Information, Head Office, and Major Competitors
Table 67. Smart Cells International Ltd. Major Business
Table 68. Smart Cells International Ltd. Cord Blood Stem Cells Product and Solutions
Table 69. Smart Cells International Ltd. Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Cryoviva India Corporate Information, Head Office, and Major Competitors
Table 71. Cryoviva India Major Business
Table 72. Cryoviva India Cord Blood Stem Cells Product and Solutions
Table 73. Cryoviva India Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Cordvida Corporate Information, Head Office, and Major Competitors
Table 75. Cordvida Major Business
Table 76. Cordvida Cord Blood Stem Cells Product and Solutions
Table 77. Cordvida Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. China Cord Blood Corporation Corporate Information, Head Office, and Major Competitors
Table 79. China Cord Blood Corporation Major Business
Table 80. China Cord Blood Corporation Cord Blood Stem Cells Product and Solutions
Table 81. China Cord Blood Corporation Cord Blood Stem Cells Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Global Cord Blood Stem Cells Revenue (USD Million) by Players (2019-2021)
Table 83. Global Cord Blood Stem Cells Revenue Share by Players (2019-2021)
Table 84. Breakdown of Cord Blood Stem Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Cord Blood Stem Cells Players Head Office, Products and Services Provided
Table 86. Cord Blood Stem Cells Mergers & Acquisitions in the Past Five Years
Table 87. Cord Blood Stem Cells New Entrants and Expansion Plans
Table 88. Global Cord Blood Stem Cells Revenue (USD Million) by Type (2016-2021)
Table 89. Global Cord Blood Stem Cells Revenue Share by Type (2016-2021)
Table 90. Global Cord Blood Stem Cells Revenue Forecast by Type (2021-2026)
Table 91. Global Cord Blood Stem Cells Revenue by Application (2016-2021)
Table 92. Global Cord Blood Stem Cells Revenue Forecast by Application (2021-2026)
Table 93. North America Cord Blood Stem Cells Revenue by Type (2016-2021) & (USD Million)
Table 94. North America Cord Blood Stem Cells Revenue by Type (2021-2026) & (USD Million)
Table 95. North America Cord Blood Stem Cells Revenue by Application (2016-2021) & (USD Million)
Table 96. North America Cord Blood Stem Cells Revenue by Application (2021-2026) & (USD Million)
Table 97. North America Cord Blood Stem Cells Revenue by Country (2016-2021) & (USD Million)
Table 98. North America Cord Blood Stem Cells Revenue by Country (2021-2026) & (USD Million)
Table 99. Europe Cord Blood Stem Cells Revenue by Type (2016-2021) & (USD Million)
Table 100. Europe Cord Blood Stem Cells Revenue by Type (2021-2026) & (USD Million)
Table 101. Europe Cord Blood Stem Cells Revenue by Application (2016-2021) & (USD Million)
Table 102. Europe Cord Blood Stem Cells Revenue by Application (2021-2026) & (USD Million)
Table 103. Europe Cord Blood Stem Cells Revenue by Country (2016-2021) & (USD Million)
Table 104. Europe Cord Blood Stem Cells Revenue by Country (2021-2026) & (USD Million)
Table 105. Asia-Pacific Cord Blood Stem Cells Revenue by Type (2016-2021) & (USD Million)
Table 106. Asia-Pacific Cord Blood Stem Cells Revenue by Type (2021-2026) & (USD Million)
Table 107. Asia-Pacific Cord Blood Stem Cells Revenue by Application (2016-2021) & (USD Million)
Table 108. Asia-Pacific Cord Blood Stem Cells Revenue by Application (2021-2026) & (USD Million)
Table 109. Asia-Pacific Cord Blood Stem Cells Revenue by Region (2016-2021) & (USD Million)
Table 110. Asia-Pacific Cord Blood Stem Cells Revenue by Region (2021-2026) & (USD Million)
Table 111. South America Cord Blood Stem Cells Revenue by Type (2016-2021) & (USD Million)
Table 112. South America Cord Blood Stem Cells Revenue by Type (2021-2026) & (USD Million)
Table 113. South America Cord Blood Stem Cells Revenue by Application (2016-2021) & (USD Million)
Table 114. South America Cord Blood Stem Cells Revenue by Application (2021-2026) & (USD Million)
Table 115. South America Cord Blood Stem Cells Revenue by Country (2016-2021) & (USD Million)
Table 116. South America Cord Blood Stem Cells Revenue by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Cord Blood Stem Cells Revenue by Type (2016-2021) & (USD Million)
Table 118. Middle East & Africa Cord Blood Stem Cells Revenue by Type (2021-2026) & (USD Million)
Table 119. Middle East & Africa Cord Blood Stem Cells Revenue by Application (2016-2021) & (USD Million)
Table 120. Middle East & Africa Cord Blood Stem Cells Revenue by Application (2021-2026) & (USD Million)
Table 121. Middle East & Africa Cord Blood Stem Cells Revenue by Country (2016-2021) & (USD Million)
Table 122. Middle East & Africa Cord Blood Stem Cells Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cord Blood Stem Cells Picture
Figure 2. Global Cord Blood Stem Cells Revenue Market Share by Type in 2020
Figure 3. Allogeneic Stem Cell
Figure 4. Autologous Stem Cell
Figure 5. Cord Blood Stem Cells Revenue Market Share by Application in 2020
Figure 6. Autoimmune Diseases Picture
Figure 7. Immunodeficiencies Picture
Figure 8. Malignancies,Caners Picture
Figure 9. Solid Tumors Picture
Figure 10. Others Picture
Figure 11. Global Cord Blood Stem Cells Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Cord Blood Stem Cells Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Cord Blood Stem Cells Revenue Market Share by Region (2016-2026)
Figure 14. Global Cord Blood Stem Cells Revenue Market Share by Region in 2020
Figure 15. North America Cord Blood Stem Cells Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Cord Blood Stem Cells Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Cord Blood Stem Cells Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Cord Blood Stem Cells Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Cord Blood Stem Cells Market Drivers
Figure 20. Cord Blood Stem Cells Market Restraints
Figure 21. Cord Blood Stem Cells Market Trends
Figure 22. Advanced Cell Technology Recent Developments and Future Plans
Figure 23. California Stem Cell Recent Developments and Future Plans
Figure 24. Cytori Therapeutics Recent Developments and Future Plans
Figure 25. Mesoblast Limited Recent Developments and Future Plans
Figure 26. Opexa Therapeutics Inc. Recent Developments and Future Plans
Figure 27. Athersys Inc. Recent Developments and Future Plans
Figure 28. Geron Corporation Recent Developments and Future Plans
Figure 29. Neostem Inc. Recent Developments and Future Plans
Figure 30. CBR Systems, Inc. Recent Developments and Future Plans
Figure 31. Cordlife Recent Developments and Future Plans
Figure 32. Cryo-Cell Recent Developments and Future Plans
Figure 33. Cryo-Save AG (A Group of Esperite) Recent Developments and Future Plans
Figure 34. Lifecell Recent Developments and Future Plans
Figure 35. Stemcyte Recent Developments and Future Plans
Figure 36. Viacord Recent Developments and Future Plans
Figure 37. Smart Cells International Ltd. Recent Developments and Future Plans
Figure 38. Cryoviva India Recent Developments and Future Plans
Figure 39. Cordvida Recent Developments and Future Plans
Figure 40. China Cord Blood Corporation Recent Developments and Future Plans
Figure 42. Global Cord Blood Stem Cells Revenue Share by Players in 2020
Figure 43. Cord Blood Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 44. Global Top 3 Players Cord Blood Stem Cells Revenue Market Share in 2020
Figure 45. Global Top 10 Players Cord Blood Stem Cells Revenue Market Share in 2020
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 47. Global Cord Blood Stem Cells Revenue Share by Type in 2020
Figure 48. Global Cord Blood Stem Cells Market Share Forecast by Type (2021-2026)
Figure 49. Global Cord Blood Stem Cells Revenue Share by Application in 2020
Figure 50. Global Cord Blood Stem Cells Market Share Forecast by Application (2021-2026)
Figure 51. North America Cord Blood Stem Cells Sales Market Share by Type (2016-2026)
Figure 52. North America Cord Blood Stem Cells Sales Market Share by Application (2016-2026)
Figure 53. North America Cord Blood Stem Cells Revenue Market Share by Country (2016-2026)
Figure 54. United States Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Canada Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Mexico Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Europe Cord Blood Stem Cells Sales Market Share by Type (2016-2026)
Figure 58. Europe Cord Blood Stem Cells Sales Market Share by Application (2016-2026)
Figure 59. Europe Cord Blood Stem Cells Revenue Market Share by Country (2016-2026)
Figure 60. Germany Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. France Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. United Kingdom Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Russia Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Italy Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Asia-Pacific Cord Blood Stem Cells Sales Market Share by Type (2016-2026)
Figure 66. Asia-Pacific Cord Blood Stem Cells Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Cord Blood Stem Cells Revenue Market Share by Region (2016-2026)
Figure 68. China Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Japan Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South Korea Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. India Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Southeast Asia Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Australia Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South America Cord Blood Stem Cells Sales Market Share by Type (2016-2026)
Figure 75. South America Cord Blood Stem Cells Sales Market Share by Application (2016-2026)
Figure 76. South America Cord Blood Stem Cells Revenue Market Share by Country (2016-2026)
Figure 77. Brazil Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Argentina Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Middle East and Africa Cord Blood Stem Cells Sales Market Share by Type (2016-2026)
Figure 80. Middle East and Africa Cord Blood Stem Cells Sales Market Share by Application (2016-2026)
Figure 81. Middle East and Africa Cord Blood Stem Cells Revenue Market Share by Country (2016-2026)
Figure 82. Turkey Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Saudi Arabia Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. UAE Cord Blood Stem Cells Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
世界の幹細胞臍帯血市場規模・現状・予測（2021年-2027年） Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered uniq…- 世界の造血幹細胞（HSC）市場 2021：企業別、地域別、種類・用途別 The Hematopoietic Stem Cells (HSCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の造血幹細胞移植（HSCT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hematopoietic Stem Cell Transplantation (HSCT) Market The global Hematopoietic Stem Cell Transplantation (HSCT) market size is projected to reach US$ 24 million by 2026, from US$ 15 million in 2019, at a CAGR of 7.3% during 2021-2026. With industry-standard accur…
- 世界の造血幹細胞移植（HSCT）市場 2021：企業別、地域別、種類・用途別 The Hematopoietic Stem Cell Transplantation (HSCT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 世界の自家幹細胞ベース治療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…